Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326 (7 June), doi:10.1136/bmj.326.7401.0
Neuraminidase inhibitors are clinically effective for treating and preventing influenza, although evidence is limited for certain population groups and for all prevention strategies. Cooper and colleagues (p 1235) conducted a systematic review and meta-analysis of 17 randomised controlled trials of zanamivir and oseltamivir. They found that treating otherwise healthy adults and children with either drug reduces the duration of symptoms by 0.4-1.0 days. The treatment also lowers the risk of complications that require antibiotics by 29-43% when it is given within 48 hours of onset of symptoms. Given prophylactically, the drugs reduced the odds of developing flu by 70-90%.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?